InvestorsHub Logo
Followers 840
Posts 120476
Boards Moderated 18
Alias Born 09/05/2002

Re: None

Friday, 08/21/2015 9:27:55 AM

Friday, August 21, 2015 9:27:55 AM

Post# of 108192
ADXS, AZN start phase-2 trial of ADXS-HPV + Durvalumab (AZN’s checkpoint inhibitor) in HPV-associated (cervical, H&N) cancers:

http://finance.yahoo.com/news/advaxis-medimmune-commence-enrollment-phase-130500622.html

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News